Evidence map›Paper›PMID 40573925›Full record

ArticleVaccines2025

Target Trial Emulation of the Modified Vaccinia Ankara-Bavarian Nordic Vaccine for Pre-Exposure Mpox Prevention in At-Risk Populations.

Clara Suñer, Roser Escrig-Sarreta, Cristina Galván-Casas, Eduardo Matos, Amanda Gabster, Marcelo Wolff, Dan Ouchi, Andrea Alemany, Hugo Sánchez, Sandra Huaman and 15 more

Abstract read
In one paragraph

Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Clara SuñerSkin NTDs and STI Section, Fight Infections Foundation, Germans Trias i Pujol University Hospital, 08916 Badalona, Spain.ORCID 0000-0003-2581-8864
Roser Escrig-SarretaSkin NTDs and STI Section, Fight Infections Foundation, Germans Trias i Pujol University Hospital, 08916 Badalona, Spain.ORCID 0009-0009-1095-4039
Cristina Galván-CasasSkin NTDs and STI Section, Fight Infections Foundation, Germans Trias i Pujol University Hospital, 08916 Badalona, Spain.ORCID 0000-0002-9662-9537
Eduardo MatosInfectology Department, Arzobispo Loayza National Hospital, Lima 15082, Peru.ORCID 0000-0002-3832-1657
Amanda GabsterThe Gorgas Memorial Institute for Health Studies, Panama City 0801, Panama.ORCID 0000-0002-7712-0444
Marcelo WolffSan Borja Arriarán Hospital, Arriarán Foundation, Santiago de Chile 8360160, Chile.
Dan OuchiSkin NTDs and STI Section, Fight Infections Foundation, Germans Trias i Pujol University Hospital, 08916 Badalona, Spain.
Andrea AlemanySkin NTDs and STI Section, Fight Infections Foundation, Germans Trias i Pujol University Hospital, 08916 Badalona, Spain.
Hugo SánchezRecruitment and Retention Area, Center for Technological, Biomedical and Environmental Research (CITBM), Mayor de San Marcos National University, Lima 07006, Peru.
Sandra HuamanComprehensive Medical Center Semedic, Lima 15001, Peru.
Dixennia BejaranoThe Gorgas Memorial Institute for Health Studies, Panama City 0801, Panama.
Lourdes Carrés-EsteveFira BCN Vaccination Centre, Catalan Health Institute, 08007 Barcelona, Spain.
Cristina Santiago-FernándezFira BCN Vaccination Centre, Catalan Health Institute, 08007 Barcelona, Spain.
Javier Corral-RubioGeneral Surgery Department, Germans Trias i Pujol University Hospital, 08916 Badalona, Spain.
Adrià MendozaBCN CheckPoint, Projecte dels NOMS Hispanosida, 08015 Barcelona, Spain.
Àngel RiveroBCN CheckPoint, Projecte dels NOMS Hispanosida, 08015 Barcelona, Spain.ORCID 0000-0003-2136-0702
Vicente DescalzoDrassanes-Vall d'Hebron STI Unit, 08001 Barcelona, Spain.
Eva OrvizSandoval Health Center, Health Research Institute of the San Carlos Clinical Hospital (IdISSC), San Carlos Clinical Hospital, 28040 Madrid, Spain.ORCID 0000-0002-2684-3431
Héctor Martínez-RiverosCentre of Epidemiological Studies on Sexually Transmitted Infections and AIDS of Catalunya (CEEISCAT), Department of Health, Government of Catalonia, 08916 Badalona, Spain.ORCID 0000-0003-3372-6134
Leonardo Méndez-BooPrimary Care Services Information System (SISAP), Institut Català de la Salut (ICS), 08007 Barcelona, Spain.ORCID 0000-0002-9215-4378
Carmen CabezasPublic Health Secretary, Health Department of the Government of Catalonia, 08028 Barcelona, Spain.
Araceli Arce-ArnáezDirección General de Salud Pública, Comunidad de Madrid Consejeria de Sanidad, 28009 Madrid, Spain.
Michael MarksClinical Research Department, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.ORCID 0000-0002-7585-4743
Oriol MitjàSkin NTDs and STI Section, Fight Infections Foundation, Germans Trias i Pujol University Hospital, 08916 Badalona, Spain.
Remain Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

efficacympoxMVA-BNsafetytarget trial emulationvaccine

Identifiers

PMID40573925
PMCPMC12197430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.